Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment

Mirogabalin (DS‐5565) is a novel preferentially selective α(2)δ‐1 ligand being developed for the treatment of diabetic peripheral neuropathic pain and postherpetic neuralgia. The current multicenter open‐label study determined the effect of varying degrees of renal impairment on the pharmacokinetics...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Manabu, Tajima, Naoyuki, Shimizu, Takako, Sugihara, Masahiro, Furihata, Kenichi, Harada, Kazuhiro, Ishizuka, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Special Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763271/
https://www.ncbi.nlm.nih.gov/pubmed/28834546
http://dx.doi.org/10.1002/jcph.974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763271/
https://www.ncbi.nlm.nih.gov/pubmed/28834546
http://dx.doi.org/10.1002/jcph.974

Ejemplares similares